Edward Greeno

1.8k total citations
40 papers, 1.3k citations indexed

About

Edward Greeno is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Edward Greeno has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Surgery and 10 papers in Cancer Research. Recurrent topics in Edward Greeno's work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroendocrine Tumor Research Advances (4 papers). Edward Greeno is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroendocrine Tumor Research Advances (4 papers). Edward Greeno collaborates with scholars based in United States, Spain and Chile. Edward Greeno's co-authors include Tufia C. Haddad, Charles F. Moldow, R Bach, Daniel J. Weisdorf, Jeffrey McCullough, Todd M. Tuttle, Patrick W. Mantyh, G M Vercellotti, Timothy D. Sielaff and Eileen M. O’Reilly and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Edward Greeno

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward Greeno United States	19	491	304	252	232	205	40	1.3k
Shinichiro Horiguchi Japan	21	587 1.2×	395 1.3×	106 0.4×	275 1.2×	332 1.6×	106	1.5k
Elliott B. Grossbard United States	22	288 0.6×	183 0.6×	127 0.5×	493 2.1×	337 1.6×	32	2.1k
G. Steger Austria	18	721 1.5×	94 0.3×	135 0.5×	148 0.6×	218 1.1×	54	1.2k
Arnaldo Arbini United States	25	433 0.9×	126 0.4×	85 0.3×	408 1.8×	905 4.4×	55	1.9k
Laura L. Swystun Canada	20	173 0.4×	148 0.5×	300 1.2×	815 3.5×	454 2.2×	47	2.0k
Herbert Stöger Austria	19	562 1.1×	198 0.7×	61 0.2×	36 0.2×	165 0.8×	68	1.1k
K.A. Rickard Australia	19	254 0.5×	263 0.9×	139 0.6×	881 3.8×	239 1.2×	68	1.8k
Peter Browett New Zealand	22	508 1.0×	98 0.3×	40 0.2×	724 3.1×	453 2.2×	91	1.7k
Richard D. Press United States	31	179 0.4×	152 0.5×	159 0.6×	1.9k 8.3×	550 2.7×	105	2.8k
Ulf‐Henrik Mellqvist Sweden	24	664 1.4×	129 0.4×	124 0.5×	1.4k 6.0×	739 3.6×	60	2.2k

Countries citing papers authored by Edward Greeno

Since Specialization

Citations

This map shows the geographic impact of Edward Greeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Greeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Greeno more than expected).

Fields of papers citing papers by Edward Greeno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Greeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Greeno. The network helps show where Edward Greeno may publish in the future.

Co-authorship network of co-authors of Edward Greeno

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Greeno. A scholar is included among the top collaborators of Edward Greeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Greeno. Edward Greeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parikh, Romil R, Shahnaz Sultan, Edward Greeno, et al.. (2024). Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review. JNCI Journal of the National Cancer Institute. 117(2). 240–252. 2 indexed citations

Kizy, Scott, Ariella M. Altman, Jane Yuet Ching Hui, et al.. (2018). Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy. HPB. 20. S571–S571. 1 indexed citations

Hurwitz, Herbert I., Eric Van Cutsem, Johanna C. Bendell, et al.. (2018). Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. Investigational New Drugs. 36(4). 683–695. 87 indexed citations

Kirby, Marie K., Ryne C. Ramaker, Jason Gertz, et al.. (2016). RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long‐term survival and reveals a role forANGPTL4. Molecular Oncology. 10(8). 1169–1182. 63 indexed citations

Goldstein, David, Daniel D. Von Hoff, Malcolm J. Moore, et al.. (2015). Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT). European Journal of Cancer. 52. 85–91. 31 indexed citations

Jensen, Eric H., Chung Lee, Todd M. Tuttle, et al.. (2013). Neoadjuvant interferon‐based chemoradiation for borderline resectable and locally advanced pancreas cancer: a Phase II pilot study. HPB. 16(2). 131–139. 17 indexed citations

Khatri, Amit, Bryan Williams, Richard C. Brundage, et al.. (2013). SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours. British Journal of Cancer. 110(2). 304–312. 21 indexed citations

Dudeja, Vikas, Edward Greeno, Sidney P. Walker, & Eric H. Jensen. (2012). Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression. HPB. 15(9). 661–667. 29 indexed citations

Picozzi, Vincent J., Ross A. Abrams, Paul A. Decker, et al.. (2010). Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031. Annals of Oncology. 22(2). 348–354. 76 indexed citations

10.

Arnoletti, J. Pablo, Andrey Frolov, M Eloubeidi, et al.. (2010). A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 67(4). 891–897. 28 indexed citations

11.

Bardia, Aditya, Edward Greeno, Robert C. Miller, et al.. (2009). Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis?. Colorectal Disease. 12(4). 312–315. 19 indexed citations

12.

Haddad, Tufia C. & Edward Greeno. (2006). Chemotherapy-induced thrombosis. Thrombosis Research. 118(5). 555–568. 283 indexed citations

13.

Greeno, Edward, Jeffrey McCullough, & Daniel J. Weisdorf. (2006). Platelet utilization and the transfusion trigger: a prospective analysis. Transfusion. 47(2). 201–205. 78 indexed citations

14.

Tuttle, Todd M., et al.. (2006). Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 13(12). 1627–1632. 43 indexed citations

15.

Sielaff, Timothy D., et al.. (2006). Staged Laparoscopic Infusion of Hyperthermic Intraperitoneal Chemotherapy After Cytoreductive Surgery. Journal of Gastrointestinal Surgery. 10(7). 1038–1043. 18 indexed citations

16.

Kosari, Kambiz, et al.. (2002). Local, Intrahepatic, and Systemic Recurrence Patterns After Radiofrequency Ablation of Hepatic Malignancies. Journal of Gastrointestinal Surgery. 6(2). 255–263. 63 indexed citations

17.

Coad, James E., et al.. (2002). Cholecystitis as the presenting manifestation of acute myeloid leukemia. American Journal of Hematology. 70(3). 254–256. 9 indexed citations

18.

Dahl, David, et al.. (1999). Human Granulocytic Ehrlichiosis Presenting with Acute Renal Failure and Mimicking Thrombotic Thrombocytopenic Purpura. American Journal of Nephrology. 19(6). 677–681. 15 indexed citations

19.

Greeno, Edward, Patrick W. Mantyh, G M Vercellotti, & Charles F. Moldow. (1993). Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium.. The Journal of Experimental Medicine. 177(5). 1269–1276. 70 indexed citations

20.

Greeno, Edward, et al.. (1983). The diels-alder reaction of methyl propiolate with 1-vinylcycloalkenes. Tetrahedron Letters. 24(3). 241–244. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact